-
News Center
-
2023-09-28Createrna Receives Capital Injection from Well-known Investment Institutions
-
2023-06-25Createrna Announces Completion of Series A Financing at Its Strategic Investment Press Conference in Wuhan
-
2022-07-17MY004567 tablets was approved by the FDA US. for clinical trials implied
-
2022-02-16The application for clinical trial of MY008211A tablet was officially accepted by the State Food and Drug Administration
-
2021-08-11MY004567 tablets was clinically approved by FDS
-
2020-11-04Createrna was invited to participate in the Chinese Pharmaceutical Innovation Investment Forum
- 1